New York Times reporter, author of an article in today’s paper about Washington State lawmakers and their efforts to regulate of prescription painkillers.
Barry Meier appears in the following:
The Opioid Narratives
Wednesday, March 27, 2019
OxyContin Makers Settle Opioid Lawsuit
Wednesday, March 27, 2019
The Lie That Opioids Aren't Addictive
Friday, October 20, 2017
What Happened to an FBI Agent Who Vanished in Iran
Wednesday, August 03, 2016
Please Explain: Pain Medication
Friday, August 02, 2013
This week we're following up on Please Explain: Pain to find out more about pain killers. Barry Meier, New York Times reporter and author of A World of Hurt: Fixing Pain Medicine’s Biggest Mistake, talks about how pain medications work, how over the counter analgesics compare to prescription pain killers, and the problems of pain killer addiction.
Food vs. Drug
Wednesday, November 28, 2012
Barry Meier, reporter for The New York Times covering business, public health and the law, talks about the FDA's investigation into energy drink-related deaths, and how the agency regulates products that straddle the line between food and drug.
Unapproved Hip Replacement Caused Pain Worldwide
Wednesday, February 15, 2012
In 2009, the Food and Drug Administration rejected an artificial hip manufactured by Johnson & Johnson. However, the company continued to sell the hip replacement in Europe and marketed a related model stateside. More than 90,000 patients worldwide used these faulty devices, and resulted in painful corrective surgery for many. In the wake of an August 2010 recall and thousands of lawsuits, Johnson & Johnson has lost at least $3 billion.
Fail: Hip Replacements
Tuesday, October 04, 2011
Barry Meier, reporter for New York Times business, public health and law, discusses his reports on the problems with metal-on-metal hip replacement devices.
When a Solution Becomes a Problem: Doctors and Lawmakers on Opiate Painkillers
Thursday, July 29, 2010
Today an FDA advisory panel meets with lawmakers to hammer out voluntary best practices for doctors who prescribe opiates. The regulation of opioid drugs like Oxycontin has loosened in recent years, as patient advocates asked for powerful narcotic painkillers for end-of-life care and cancer treatments. But in loosening restrictions for such cases, the FDA opened a window for wider prescriptions — and for abuse.